Background -Cystic fibrosis is an inherited condition with a high mortality and morbidity. The aims of this study were to assess quality of life in a population of adults with cystic fibrosis, to compare quality oflife with published scores from a healthy population and other patient groups, and to examine the relation between quality oflife and other measured clinical variables. (Thorax 1996;51:936-940) 
these problems affect normal activities of daily life. It has been validated and tested for reliability and has previously been used to assess quality of life prior to and following heart-lung transplantation in patients with cystic fibrosis.7 Part 1 consists of weighted questions which assess perceived distress or disability in six dimensions: energy, pain, emotion, sleep, social isolation, and physical mobility. Part 2 examines which of seven areas of daily living are affected by disease by a "yes/no" response to the question: "Is your present state of health causing problems with your.
?" The seven areas of daily living assessed in part 2 are: employment, looking after the home, social life, home life (relationships with other people in the home), sex life, hobbies, and holidays. The mean score in a healthy population varies with age and sex, and norms for a healthy population have been published.8 Spirometric tests were performed on a dry wedge spirometer and the forced expiratory volume in one second (FEV1) % predicted, forced vital capacity (FVC) % predicted,9 FEV1 :FVC ratio, and body mass index (weight/height2) were calculated.
DATA ANALYSIS All statistical tests were performed two sided and the level of significance was set at p < 0.05. The quality of life data were not normally distributed and therefore nonparametric statistical methods were used. The median and interquartile range are presented in the tables, but mean values are presented in the figures to allow comparison with reference data which are presented as mean values in the original publications.8 ' 1 In order to assess the data the results were expressed as a percentage of the norm for that age and sex. To compare our data with the norms the distribution was tested for difference from 100% using a Wilcoxon matched pairs signed rank test for part 1 and a x2 test for part 2. In order to analyse age related trends the data were summarised using a frequency count as many of the scores were zero. Differences between age groups for parts 1 and 2 were tested using logistic ANOVA. Factor analysis showed that there was no additional information gained from question 2 of the cystic fibrosis supplement over question 1 (time in hospital and hours worked over the past three and 12 months, respectively) so the data from question 2 were ignored for the purpose of the analysis. Correlation between quality of life scores and clinical variables was assessed using Spearman's rank correlation coefficient.
Results
The subjects were the first 240 patients (100 women) who attended the outpatient clinic for their annual review appointment (the total clinic population is approximately 350 patients). Their median age was 27 years (range 16-56); mean (SD) FEVy was 49 (26)% predicted, mean FVC 68 (26) % predicted, and the mean FEV5:FVC ratio was 59(16)%. under 20 age group). Men had significantly worse scores than norms in the dimensions of energy, pain, and social isolation, while women had significantly worse scores than norms in the dimensions of pain, emotion, and sleep. The mean scores in part 1 grouped according to age and compared with the published norm are shown graphically for men and women in figs 1 and 2, respectively. For men there is an age related trend in several dimensions with perceived quality of life in older men increasingly worse than scores in a healthy population of the same age. This age related trend was statistically significant in the dimensions of emotion, sleep, and social isolation. The same pattern was not seen in women; in fact, in the older age groups women with cystic fibrosis often perceived their quality of life to be better than that perceived by healthy subjects of the same age. There were no statistically significant age related trends in women.
The results for part 2 exam- ple, that the impact of troublesome varicose veins on an individual is in anyway comparable to the impact of a disease such as cystic fibrosis. The scale for a person who is used to being in good health appears to be greatly expanded and therefore measured improvement following procedures in minor conditions would be expected to be relatively large leading to a falsely low cost per unit of quality of life gained.
In conclusion, the Nottingham Health Profile appears to be a satisfactory tool for assessing quality of life in adults with cystic fibrosis. There is a strong relation between perceived quality of life and other measures of disease severity such as FEV1, breathlessness, and the time spent on home treatment. Men and women with cystic fibrosis have different patterns of perceived quality of life, the reaons for which have not been studied in this group. We warn against the danger of using such quality of life measures to attempt to compare different groups of patients in health economics planning exercises.
